Pyros Pharmaceuticals, Inc. — Form D/A
Pyros Pharmaceuticals, Inc. of Parsippany, NJ, a company, filed a Form D amendment with the SEC on 2020-08-25. The offering totals $6.0M, of which $5.9M was reported sold. Industry: Other.
Offering
- Filed: 2020-08-25
- Form: D/A
- Accession: 0001231919-20-000056
- Industry: Other
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $5.9M
- Remaining: $65K
- Investors: 59
- Date of first sale: 2020-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364840
Issuer
- Name: Pyros Pharmaceuticals, Inc.
- CIK: 0001809245
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2001 Route 46, Suite 310, Parsippany, NJ, 07054
- Phone: 201-743-9468
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Michael Smith | Director | Austin, TX |
| Michael Smith | Executive Officer | Austin, TX |
| Edwin Urrutia | Director | Parsippany, NJ |
| Edwin Urrutia | Executive Officer | Parsippany, NJ |
| Ron Tilles | Director | Parsippany, NJ |
Other filings by this issuer (2)
More